Background

HKU5-CoV-2 is a newly discovered bat coronavirus identified by Chinese scientists that has demonstrated the ability to bind to human ACE2 receptors, similar to SARS-CoV-2. Currently, there are no reported human cases of HKU5-CoV-2.

Resolution Criteria

This market will resolve YES if there are 100 or more confirmed human cases of HKU5-CoV-2 reported by credible health organizations (WHO, CDC, or equivalent national health authorities, if there is clear ballpark consensus) by December 31, 2025, 11:59 PM ET. The market will resolve NO if fewer than 100 confirmed cases are reported by this deadline.